Ocugen receives provisional approval for gene therapy in Bahamas

Atlas Energy secures power equipment deals with AI lab customer

Investing.com · News 11m ago

Legend Biotech reports 5-year CARVYKTI data in myeloma patients

Investing.com · News 11m ago

Fate Therapeutics receives $15m CIRM grant for lupus trial

Investing.com · News 11m ago

C4 Therapeutics presents cemsidomide trial biomarker data

Investing.com · News 11m ago

Madison Dearborn to acquire Marygold for $2 per share in cash

Investing.com · News 11m ago

FactSet appoints Marcel Prins to board of directors

Investing.com · News 11m ago

InvestingPro’s fair value call preceded 46% drop in Aurora stock

Investing.com · News 13m ago

Italy regulator closes P&G hair removal device probe after ad commitments

Investing.com · News 15m ago

Why is Comcast stock sliding today?

Investing.com · News 15m ago

NIH funding cuts delayed a promising childhood brain cancer trial. Patients lost time they didn't have.

CNBC · Economy 16m ago